|
CMS
MCID: CNG001
|
Congenital Myasthenic Syndrome malady |
|
21 genes, 1 tissue, 193 related diseases, 6 phenotypes, 68 articles, clinical trials, genetic tests.
|
|
|
Sources: 31NINDS, 17Genetics Home Reference, 44Wikipedia, 15GeneReviews, 22MalaCards See all sources Export this MalaCard |
Genetics Home Reference: Congenital myasthenic syndrome is a group of conditions characterized by muscle weakness (myasthenia) that worsens with physical exertion. The muscle weakness typically begins in early childhood but can also appear in adolescence or adulthood. Facial muscles, including muscles that control the eyelids, muscles that move the eyes, and muscles used for chewing and swallowing, are most commonly affected. However, any of the muscles used for movement (skeletal muscles) can be affected in this condition. Due to muscle weakness, affected infants may have feeding difficulties. Development of motor skills such as crawling or walking may be delayed. The severity of the myasthenia varies greatly, with some people experiencing minor weakness and others having such severe weakness that they are unable to walk.17
MalaCards: Congenital Myasthenic Syndrome, also known as congenital myasthenia, is related to lambert-eaton myasthenic syndrome and slow-channel congenital myasthenic syndrome. An important gene associated with Congenital Myasthenic Syndrome is CHRND (cholinergic receptor, nicotinic, delta (muscle)), and among its related pathways are Highly sodium permeable acetylcholine nicotinic receptors and Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction). The compounds alpha-bungarotoxin and alpha-conotoxin ei have been mentioned in the context of this disorder. Affiliated tissues include skeletal muscle, and related mouse phenotypes are respiratory system and muscle. NINDS: All forms of myasthenia are due to problems in the communication between nerve cells and muscles. Most involve the activities of neurotransmitters. Neurotransmitters are chemicals that allow neurons to relay information from one cell to the next. For neurotransmitters to be effective, the nerve cell must release the neurotransmitter properly, and the muscle cell must be able to detect the neurotransmitter and respond to its signal properly.31 Wikipedia: Congenital myasthenic syndrome (CMS) is an inherited neuromuscular disorder caused by defects of several...44 more... GeneReviews summary for cms |
|
Sources: 6Disease Ontology, 15GeneReviews, 16GeneTests, 17Genetics Home Reference, 31NINDS, 8DISEASES, 32Novoseek , 43UMLS, 27NCIt, 24MeSH See all sources |
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for congenital myasthenic syndrome Drug clinical trials:Search ClinicalTrials for congenital myasthenic syndrome Search NIH Clinical Center for congenital myasthenic syndrome Search CenterWatch for congenital myasthenic syndrome |
|
Sources: 16GeneTests See all sources |
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to congenital myasthenic syndrome:22Skeletal muscle
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to congenital myasthenic syndrome:25
|
|
Sources: 35PubMed See all sources |
Articles related to congenital myasthenic syndrome:(show top 50) (show all 68)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 38Reactome, 34PharmGKB, 36QIAGEN, 20KEGG, 10EMD Millipore See all sources |
Pathways related to congenital myasthenic syndrome according to GeneDecks:
|
|
Sources: 32Novoseek , 42Tocris Bioscience, 9DrugBank, 18HMDB, 34PharmGKB See all sources |
Compounds related to congenital myasthenic syndrome according to GeneDecks:(show all 24)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to congenital myasthenic syndrome according to GeneDecks:
Biological processes related to congenital myasthenic syndrome according to GeneDecks:(show all 8)
Molecular functions related to congenital myasthenic syndrome according to GeneDecks:
|
